RA Capital Nexus Fund IV, L.P. — SEC Form 4 filings

SEC reporting owner CIK 2053586. 1 Form 4 filing on record with FilingPulse; latest filed 2026-05-06.

Transaction summary — filings shown

Covers all 1 filing on record, filed 2026-05-06 to 2026-05-06. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
Hemab Therapeutics Holdings, Inc. (COAG)Director16 legs · 2,840,429 sh · $52,222,9469

Form 4 filings — RA Capital Nexus Fund IV, L.P.

FiledFormIssuerReported transactionsSource
2026-05-064Hemab Therapeutics Holdings, Inc. (COAG)
jointly with RA CAPITAL MANAGEMENT, L.P., RA Capital Healthcare Fund LP, RA Capital Nexus Fund II, L.P., Kolchinsky Peter, Shah Rajeev M.
Conversion (C): 3,607,846 · Conversion (C): 1,009,052 · Conversion (C): 221,188 · Purchase (P): 2,541,250 @ $18 · Purchase (P): 133,750 @ $18 · Purchase (P): 87,143 @ $24.59 · +9 moreEDGAR

FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=2053586 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →